Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple depressive episodes and plasma postdexamethasone cortisol levels.

J H Meador-Woodruff, G Gurguis, L Grunhaus

    Biological Psychiatry
    |May 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Shaping plasticity: Alterations in glutamate transporter localization as a pathophysiological mechanism in severe mental illness.

    Molecular psychiatry·2016
    Same author

    Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons?

    Molecular psychiatry·2015
    Same author

    Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain.

    Translational psychiatry·2015
    Same author

    Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia.

    Translational psychiatry·2015
    Same author

    Transcranial magnetic stimulation is effective in the treatment of relapse of depression.

    International journal of psychiatry in clinical practice·2014
    Same author

    Sleep Electroencephalographic Studies After ECT.

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2011
    Same journal

    Domain-Derived Biomarkers of Treatment Response in Major Depressive Disorder: An Activation Likelihood Estimation Neuroimaging Meta-Analysis.

    Biological psychiatry·2026
    Same journal

    Functional connectivity of orbitofrontal cortex predicts cocaine relapse: Protective and risk circuits, individual differences, and neuromodulation implications.

    Biological psychiatry·2026
    Same journal

    Takeda G protein-coupled receptor 5 orchestrates anxiolysis by enhancing anterior paraventricular thalamic nucleus glutamatergic neuronal activity to engage distinct downstream circuits.

    Biological psychiatry·2026
    Same journal

    Neuroimaging of Heterogeneity in Neuropsychiatric Disorders: Toward Disease Progression Modeling.

    Biological psychiatry·2026
    Same journal

    Impact of Transcranial Direct Current Stimulation-Induced Electric Fields on Slowing Cognitive Decline in Older Adults With Mild Cognitive Impairment or Remitted Major Depressive Disorder: An Analysis of the PACt-MD Randomized Clinical Trial.

    Biological psychiatry·2026
    Same journal

    Remembering Jon-Kar Zubieta, M.D., Ph.D.

    Biological psychiatry·2026
    See all related articles

    Major depressive disorder (MDD) involves HPA axis dysregulation. This study found no link between a history of depression episodes and HPA axis biological markers like cortisol levels.

    Area of Science:

    • Neuroendocrinology
    • Psychiatry
    • Major Depressive Disorder Research

    Background:

    • The hypothalamic-pituitary-adrenal (HPA) axis is frequently dysregulated in individuals diagnosed with major depressive disorder (MDD).
    • Understanding the long-term implications of depressive episodes on HPA axis function is crucial for comprehending MDD pathophysiology.

    Purpose of the Study:

    • To investigate the association between the cumulative burden of past depressive episodes and HPA axis biological markers in MDD patients.
    • To determine if factors such as the number of prior depressive episodes, hospitalizations, or time since the first episode correlate with HPA axis dysregulation.

    Main Methods:

    • Assessed relationships between historical depression metrics (episode count, hospitalization frequency, time since first episode) and HPA axis activity.

    Related Experiment Videos

  • Utilized biological markers including postdexamethasone plasma cortisol levels and dexamethasone suppressor/nonsuppressor status to quantify HPA axis function.

    • Main Results:

    • No statistically significant relationships were identified between the number of past depressive episodes and HPA axis biological markers.
    • The study found no correlation between previous depression hospitalizations or the duration since the first depressive episode and cortisol levels or dexamethasone suppression status.

    Conclusions:

    • A history of depressive episodes, including their frequency or duration, does not appear to be significantly associated with HPA axis dysregulation markers in MDD.
    • These findings suggest that HPA axis dysfunction in MDD may not be directly linked to the cumulative burden of past illness history.